Netabolics
Netabolics offers an AI-driven biosimulation platform that utilizes digital human cell models to predict biological responses to pharmacological and genetic interventions. This technology enables pharmaceutical companies to efficiently identify and validate drug targets, significantly reducing the time and costs associated with drug discovery.
- Artificial Intelligence
- Data & Analytics
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$35.5KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Netabolics offers an AI-driven biosimulation platform that utilizes digital human cell models to predict biological responses to pharmacological and genetic interventions. This technology enables pharmaceutical companies to efficiently identify and validate drug targets, significantly reducing the time and costs associated with drug discovery.